Sun Pharmaceuticals Industries Ltd Share Price (SUNPHARMA)
₹1139.95▲1.25%
Overview of Sun Pharmaceuticals Industries Ltd
Key events for Sun Pharmaceuticals Industries Ltd
Sun Pharma Launches New Product Amidst Shareholder Agreement Termination - 27 Sep, 2023
Sun Pharmaceuticals Industries Ltd's subsidiary launches new product while its promoter Dilip Shanghvi terminates shareholder agreement with Suzlon Energy.
Sun Pharma Founder Signs Shareholders' Agreement with Suzlon - 26 Sep, 2023
Sun Pharmaceuticals Industries Ltd's founder signed an amended shareholders' agreement with Suzlon following a debt restructuring proposal, while Access to Medicine Foundation analysed the company's efforts to expand access to their products in LMICs.
LIC Divests 2% Stake in Sun Pharmaceuticals - 25 Sep, 2023
Life Insurance Corporation (LIC) has divested a 2% stake in Sun Pharmaceuticals Industries, reducing its stake from 5% to 3%. The transaction was done through the open market at an average floor price of Rs 973.80 per share.
Sun Pharma Reports Higher Profits Amidst Pharma Stock Decline - 22 Sep, 2023
Sun Pharmaceutical Industries Ltd reported higher profits than NSE with Rs 8,473.6 crore amidst a decline of pharma stocks by 1.9%. Sun Pharma was among the top drags in Nifty 50 index losing 1.2%.
Sun Pharma Gains in Stock Market - 21 Sep, 2023
Sun Pharmaceuticals Industries Ltd's stock gains in the market. Sumeet Bagadia recommends buying the stock due to its strong performance.
Sun Pharma Reports Q1 Results and Receives Buy Rating from Motilal Oswal - 20 Sep, 2023
Sun Pharmaceuticals Industries Ltd reports Q1 results with a drop in net profit but an increase in revenue. The company also receives a buy rating from Motilal Oswal.
MOSL Remains Positive on Sun Pharma's Innovative Products Franchise - 16 Sep, 2023
Motilal Oswal Securities Ltd (MOSL) expects Sun Pharma to exhibit a 10% CAGR over FY23-25, driven by its robust innovative products franchise targeted for global markets and superior execution in branded generics markets. MOSL also expects overall US sales CAGR of 11% to $2b over FY23-FY25, while ROW and emerging markets are expected to witness a CAGR of 12% (in CC terms) over FY23-25 to reach $2.2b.
LIC Sells Stake in Sun Pharma; Company Reports Q1 Results - 15 Sep, 2023
Life Insurance Corporation of India (LIC) has sold a 2% stake in Sun Pharmaceuticals Industries Ltd. Meanwhile, Sun Pharma reported its Q1 results with a 2% YoY net profit drop and an 11% increase in revenue.
Sun Pharma Ties Up With Pharmazz Inc To Commercialize Sovateltide In India - 14 Sep, 2023
Sun Pharmaceuticals Industries Ltd has tied up with US-based Pharmazz Inc to commercialise Sovateltide in India. LIC sold 2.011% stake in Sun Pharma.
Sun Pharma Stock Shows Bullish Trend - 13 Sep, 2023
Sun Pharmaceuticals Industries Ltd's stock price has broken out from a downward sloping channel and is trading above its 20, 50, and 200 DMA. Indicators like MACD and RSI have turned bullish on the daily charts. Nifty Pharma Index has resumed its primary uptrend.
Sun Pharma Gains Among Major Sensex Firms - 12 Sep, 2023
Sun Pharmaceuticals Industries Ltd gained significantly on September 12th, as per brokerage recommendations and being among the major gainers on Sensex.
Sun Pharma Reports Q1 Results - 11 Sep, 2023
Sun Pharmaceuticals Industries Ltd reports Q1 results with a 2% YoY drop in net profit and an 11% increase in revenue. US sales were reported at $471 million.
Sun Pharma Shares Close on Negative Note, Support at 1,105.30 - 09 Sep, 2023
Sun Pharmaceuticals Industries Ltd's shares closed the previous week with a loss of 4.09%. Immediate support for the share price is at 1,105.30 and major support is at 1,080.15. Immediate resistance is at 1,152.30 and major resistance is at 1,174.15. Trading range for the week should be between 1,058.30 and 1,199.30.
Sun Pharma Faces Profit Booking, Spurious Drug Scandal - 07 Sep, 2023
Sun Pharmaceuticals Industries Ltd faces profit booking after recent gains and spurious drug scandal. Motilal Oswal Securities and Kotak Institutional Equities recommend Sun Pharma as a top investment idea.
Sun Pharma Among Major Gainers in Sensex Pack - 06 Sep, 2023
Shares of Sun Pharma emerged as one of the major gainers from the Sensex pack. Additionally, Sun Pharma, Divi's Labs and Cipla were top gainers on the Nifty 50.
Sun Pharma Stock Sees Significant Returns - 05 Sep, 2023
Sun Pharmaceuticals Industries Ltd's stock has seen significant returns, delivering 160% gains with only a third driven by earnings. The company also emerged as the biggest gainer in the Sensex pack, climbing 2.09%.
Sun Pharma Share Price Faces Resistance at 1,122.13 - 02 Sep, 2023
Sun Pharmaceuticals Industries Ltd's share price faces immediate resistance at 1,122.13 and major support at 1,088.57 for the week. A sharp breakout is expected if it closes above 1,122.13.
Sun Pharma Loses Ground Amidst Generic Drug Shipping and Acquisition News - 01 Sep, 2023
Sun Pharmaceuticals Industries Ltd experiences losses amidst news of generic drug shipments by competitors and Torrent Pharma's potential acquisition that could surpass Sun Pharma's previous record.
Sun Pharma Plans Increased Focus on Specialty R&D Spending - 29 Aug, 2023
Sun Pharmaceuticals Industries Ltd plans to increase its focus on specialty research and development (R&D) spending by allocating 7-8% of its sales towards R&D in FY24.
Sun Pharma Gains Amid Positive News - 28 Aug, 2023
Sun Pharmaceuticals Industries Ltd gained amid positive news as it was among the top gainers in Sensex pack and Nifty Pharma index. The company also announced its plans to increase R&D spending.
Analyst Rating for Sun Pharmaceuticals Industries Ltd stock
based on 37 analysts
Based on 37 analysts offering long term price targets for Sun Pharmaceuticals Industries Ltd. An average target of ₹1232.86
Source: S&P Global Market Intelligence
Sun Pharmaceuticals Industries Ltd share Performance
- ₹1123.2₹1145.9₹1139.95
1.47%
Downside
Day's Volatility:1.99%
Upside
0.52%
- ₹892.05₹1169.7₹1139.95
21.75%
Downside
52 Weeks Volatility:24.36%
Upside
2.61%
| Returns % | |
| 1 Month Return | 0.79 % |
| 3 Month Return | 12.38 % |
| 1 Year Return | 25.49 % |
| Market Stats | |
| Previous Close | ₹1,125.85 |
| Open | ₹1,126.15 |
| Volume | 23.32L |
| Market Cap | ₹2,70,129.13Cr |
Sun Pharmaceuticals Industries Ltd Company Information
Sun Pharma's branded formulations include products for cardiovascular, central nervous system, gastroenterology, ophthalmology, and dermatology. Sun Pharma's specialty generics include injectables, inhalants, and complex products. Sun Pharma's API portfolio includes products for a range of therapeutic areas, including cardiovascular, central nervous system, gastroenterology, and dermatology.
Sun Pharma's top products include Modalert, a generic version of Modafinil for treating sleep disorders; Glocip, a generic version of Glipizide for treating diabetes; and Doxicip, a generic version of Doxycycline for treating bacterial infections. Sun Pharma's popular brands include Revital, a multivitamin supplement; Tazret, a topical retinoid for treating psoriasis; and Olmecip, a generic version of Olmesartan for treating hypertension.
Share Price: ₹1139.95 per share as on 27 Sep, 2023 04:01 PM
Market Capitalisation: ₹2,70,129.13Cr as of today
Revenue: ₹11,303.95Cr as on March 2023 (Q1 23)
Net Profit: ₹1,984.47Cr as on March 2023 (Q1 23)
Listing date: 09 Feb, 1995
Chairperson Name: Israel Makov
| Organisation | Sun Pharmaceuticals Industries Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Fundamentals of Sun Pharmaceuticals Industries Ltd
Insights on Sun Pharmaceuticals Industries Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, SUNPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 12.91% to 13.16% in Jun 2023 quarter
- POSITIVE IMPACT
Price Rise
In the last 3 years, SUNPHARMA stock has moved up by 120.7%
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 54.48% of holdings in Jun 2023 quarter
- NO EFFECT
Against Peers
In the last 1 year, Dr Reddys Laboratories Ltd has given 30.8% return, outperforming this stock by 5.3%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 11.41K Cr → 11.30K Cr (in ₹), with an average decrease of 1.0% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 16.89% to 16.48% in Jun 2023 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 9.39% to 9.29% in Jun 2023 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, 2.26K Cr → 1.98K Cr (in ₹), with an average decrease of 6.3% per quarter
Sun Pharmaceuticals Industries Ltd share Valuation
Sun Pharmaceuticals Industries Ltd in the last 5 years
Lowest (19.47x)
March 23, 2020
Today (32.08x)
September 26, 2023
Industry (47.44x)
September 26, 2023
Highest (184.63x)
August 28, 2020
Mutual Fund Holdings
| Funds | Holdings |
 ICICI Prudential Value Discovery Fund Direct Plan Growth | 6.45% |
 Mirae Asset Large Cap Fund Direct Plan Growth | 2.27% |
| ICICI Prudential India Opportunities Fund Direct Growth | 7.04% |
| ICICI Prudential Equity & Debt Fund Direct Plan Growth | 3.02% |
 HDFC Balanced Advantage Fund Direct Plan Growth Option | 1.2% |
Sun Pharmaceuticals Industries Ltd Shareholding Pattern
| Investors | Holdings % | Prev. 2 periods | 3M change |
|---|---|---|---|
| Promoter Holdings | 54.48% | 0.00 | |
| Foreign Institutions | 16.48% | ||
| Mutual Funds | 13.16% | 1.95 | |
| Retail Investors | 9.29% | ||
| Others | 6.59% | 4.02 |
Technicals of Sun Pharmaceuticals Industries Ltd share
News & Events of Sun Pharmaceuticals Industries Ltd
News
Stock Market Live Updates: Asian stocks fall on Fed rate hike anticipation
Stock Market today | Share Market Live Updates - Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 20... Read more
20 Sep, 2023 07:00 AMStocks that will see action today: September 20, 2023
Bharat Dynamics has signed a contract worth Rs 290.90 crore with the Indian Air Force. Zydus Lifesciences has received an Establishment Inspection Report from... Read more
20 Sep, 2023 07:30 AMAutoclaved Aerated Concrete (AAC) Market to reach a revised size of USD 30.84 billion by 2029
Autoclaved Aerated Concrete (AAC) Market will witness a CAGR of 6.1% for the forecast period of 2023-2029 and is likely USD 18.10 billion in 2022 to reach at US... Read more
27 Sep, 2023 11:55 AMFrequently Asked Questions
Sun Pharmaceuticals Industries Ltd (SUNPHARMA) share price today is ₹1139.95
- Today’s highest price of Sun Pharmaceuticals Industries Ltd is ₹1145.9.
- Today’s lowest price of Sun Pharmaceuticals Industries Ltd is ₹1123.2.
Today’s traded volume of Sun Pharmaceuticals Industries Ltd(SUNPHARMA) is 23.32L.
Today’s market capitalisation of Sun Pharmaceuticals Industries Ltd(SUNPHARMA) is ₹270129.13Cr.
| Sun Pharmaceuticals Industries Ltd(SUNPHARMA | Price |
|---|---|
52 Week High | ₹1169.7 |
52 Week Low | ₹892.05 |
Sun Pharmaceuticals Industries Ltd(SUNPHARMA) share price is ₹1139.95. It is down -2.54% from its 52 Week High price of ₹1169.7
Sun Pharmaceuticals Industries Ltd(SUNPHARMA) share price is ₹1139.95. It is up 27.79% from its 52 Week Low price of ₹892.05
| Sun Pharmaceuticals Industries Ltd(SUNPHARMA | Returns |
|---|---|
1 Day Returns | 14.1% |
1 Month Returns | 0.79% |
3 Month Returns | 12.38% |
1 Year Returns | 25.49% |